Blockade of cholecystokinin-A receptors has no effect on dyskinesias in Parkinson's disease.
Arnulf
I
I
Vidailhet
M
M
Bonnet
A M
AM
Descombes
S
S
Jaillon
C
C
Agid
Y
Y
Brefel
C
C
Rascol
O
O
Xie
J
J
Pollak
P
P
Cattelin
F
F
D000284:Administration, Oral; D004185:Disability Evaluation; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006801:Humans; D007210:Indoleacetic Acids / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009068:Movement / Q000502:physiology; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D011897:Random Allocation; D043886:Receptor, Cholecystokinin A; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors*; D013844:Thiazoles / Q000008:administration & dosage*
D007210:Indoleacetic Acids; D043886:Receptor, Cholecystokinin A; D011949:Receptors, Cholecystokinin; D013844:Thiazoles; C080460:SR 27897